Osman Köstek
Impact in
- Nephrology top 2%
- Gout, Hyperuricemia, Uric Acid
- Parathyroid Disorders and Treatments
- Geriatrics and Gerontology top 10%
Papers in
- Oncology 32
- Inflammatory Biomarkers in Disease Prognosis 8
- Colorectal Cancer Treatments and Studies 8
- Cancer Diagnosis and Treatment 5
- Co-authors
- Mümtaz TakırBarış AfşarMustafa ÇalışkanFeyza AksuMehmet KanbayHasan Hüseyin MutluNurşen KeleşAybala Erek
- Journals
- Journal of Clinical Oncology (4 papers)Nutrition and Cancer (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Current Problems in Cancer (2 papers)Clinical & Translational Oncology (2 papers)
- Partner nations
- TürkiyeUnited KingdomRomania
In The Last Decade
Osman Köstek
81 papers receiving 856 citations
Peers
Comparison fields: 5 of 87
- Nephrology 247
- Geriatrics and Gerontology 46
- Physiology 166
- Pathology and Forensic Medicine 109
- Endocrinology, Diabetes and Metabolism 84
Countries citing papers authored by Osman Köstek
This map shows the geographic impact of Osman Köstek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osman Köstek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osman Köstek more than expected).
Fields of papers citing papers by Osman Köstek
This network shows the impact of papers produced by Osman Köstek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osman Köstek. The network helps show where Osman Köstek may publish in the future.
Co-authors
The 25 scholars most cited alongside Osman Köstek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 0 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 1 | |
| 13 | 2020 | 5 | |
| 14 | 2020 | 4 | |
| 15 | 2020 | 4 | |
| 16 | Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer? | 2019 | 4 |
| 17 | 2019 | 2 | |
| 18 | 2018 | 3 | |
| 19 | 2015 | 5 | |
| 20 | 2015 | 30 |
About Osman Köstek
Osman Köstek is a scholar working on Nephrology, Oncology, Hepatology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 89 papers that have together received 881 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (8 papers), Renal cell carcinoma treatment (8 papers), Colorectal Cancer Treatments and Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cardiovascular Health and Disease Prevention (7 papers), Colorectal and Anal Carcinomas (6 papers), Cardiovascular Function and Risk Factors (5 papers) and Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Nephrology (247 citations), Geriatrics and Gerontology (46 citations), Physiology (166 citations), Pathology and Forensic Medicine (109 citations) and Endocrinology, Diabetes and Metabolism (84 citations). Osman Köstek has collaborated with scholars based in Türkiye, United Kingdom and Romania. Frequent co-authors include Mümtaz Takır, Barış Afşar, Mustafa Çalışkan, Feyza Aksu, Mehmet Kanbay, Hasan Hüseyin Mutlu, Nurşen Keleş, Aybala Erek, Özge Telci Çaklılı and Abdullah Özkök. Their work appears in journals such as Journal of Clinical Oncology, Nutrition and Cancer, Cancer Chemotherapy and Pharmacology, Current Problems in Cancer and Clinical & Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.